Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Houda Camara
Institution:
Centre Hospitalier Régional et Universitaire de Nancy
Observed institution:
Centre Hospitalier Régional et Universitaire de Nancy
ORCID:
0000-0002-6445-7865
Observed ORCID:
0000-0002-6445-7865
OpenAlex ID:
A5111170791
Difficult‐to‐treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment
2024
·
Bénédicte Caron
, Alexandre Habert
, et al.
·
United European Gastroenterology Journal
·
18
PDF
Circulating Methylated SEPT9 for Detection of Hepatocellular Carcinoma in Cirrhosis
2026
·
Abderrahim Oussalah
, Maël Silva Rodriguez
, et al.
·
JAMA Oncology
·
6
Clinical profiles associated with rapidly progressive interstitial lung disease in antisynthetase syndrome: A multicentric cohort study (TYPASS study)
2025
·
Maxime Billotte
, Thomas Moulinet
, et al.
·
Journal of Internal Medicine
·
6
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID
2024
·
Bénédicte Caron
, Philippe Seksik
, et al.
·
Therapeutic Advances in Gastroenterology
·
4
Bayesian Statistics: A Narrative Review on Application in Inflammatory Bowel Diseases
2025
·
Houda Camara
, Eric Vicaut
, et al.
·
Inflammatory Bowel Diseases
·
3
OS-052 Circulating methylated SEPT9 for detection of hepatocellular carcinoma in patients with cirrhosis: a prospective multicenter phase 3 diagnostic validation study
2026
·
Abderrahim Oussalah
, Maël Silva Rodriguez
, et al.
·
Journal of Hepatology
·
1
Longitudinal Trajectories of Antisynthetase Syndrome-associated Interstitial Lung Disease
2026
·
Maxime Billotte
, Houda Camara
, et al.
·
Archivos de Bronconeumología
Show more works
View as search
Works count:
7
Citation count:
38
H-index:
4
I10-index:
1
Year
Topic
Type